Haoyuan Pharmaceutical's H1 Net Profit Up 12.81% Year-on-Year, Proposes 0.9 Yuan Dividend per 10 Shares

证券时报··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Haoyuan Pharmaceutical disclosed its semi-annual report on August 26, achieving operating revenue of 1.648 billion yuan in the first half of 2026, up 25.71% year-on-year; net profit attributable to shareholders of the listed company was 171 million yuan, up 12.81% year-on-year; basic earnings per share were 0.81 yuan. The company plans to distribute a cash dividend of 0.9 yuan per 10 shares, tax included.

Impact on assets 1

Others▲